The year’s biggest dealmakers – Pfizer, Bristol Myers Squibb and AbbVie – were not among the five busiest based on a review of dealmaking data • Source: Shutterstock
Candid conversations with C-suite leaders.
Keep up with strategy, innovation and evolving trends across life science industries.
